المؤلفون: Mishra, Neha, Aden, Konrad, Blase, Johanna I, Baran, Nathan, Bordoni, Dora, Tran, Florian, Conrad, Claudio, Avalos, Diana, Jaeckel, Charlot, Scherer, Michael, Sørensen, Signe B, Overgaard, Silja H, Schulte, Berenice, Nikolaus, Susanna, Rey, Guillaume, Gasparoni, Gilles, Lyons, Paul A, Schultze, Joachim L, Walter, Jörn, Andersen, Vibeke, SYSCID Consortium, Dermitzakis, Emmanouil T, Schreiber, Stefan, Rosenstiel, Philip

المساهمون: Georges, Michel

المصدر: Genome Medicine, 14 (1), 110 (2022-09-24)

مصطلحات موضوعية: Biologics, Biomarker, Intestinal inflammation, Personalized medicine, Therapy response, Biomarkers, Tumor Necrosis Factor Inhibitors, Tumor Necrosis Factor-alpha, RNA, Interferons, Infliximab, Humans, Infliximab/therapeutic use, Interferons/therapeutic use, Prospective Studies, Inflammatory Bowel Diseases/drug therapy, Inflammatory Bowel Diseases/genetics, Inflammatory Bowel Diseases, Molecular Medicine, Molecular Biology, Genetics, Genetics (clinical), Life sciences, Genetics & genetic processes, Sciences du vivant, Génétique & processus génétiques

Relation: info:eu-repo/grantAgreement/EC/H2020/733100; https://link.springer.com/content/pdf/10.1186/s13073-022-01112-z.pdf; urn:issn:1756-994X

URL الوصول: https://orbi.uliege.be/handle/2268/302286

المؤلفون: Danese, Silvio, Colombel, Jean-Frederic, Lukas, Milan, Gisbert, Javier P, D'Haens, Geert, Hayee, Bu'hussain, Panaccione, Remo, Kim, Hyun-Soo, Reinisch, Walter, Tyrrell, Helen, Oh, Young S, Tole, Swati, Chai, Akiko, Chamberlain-James, Kirsten, Tang, Meina Tao, Schreiber, Stefan, GARDENIA Study

المساهمون: Louis, Edouard, Aboo, Nazimuddin, Ahmad, Tariq, Aldeguer Mante, Xavier, Allez, Matthieu, Almer, Sven, Altwegg, Romain, Andreu Garcia, Montserrat, Arasaradnam, Ramesh, Ardizzone, Sandro, Armuzzi, Alessandro, Arnott, Ian, Aumais, Guy, Avni-Biron, Irit, Barrow, Peter, Beales, Ian, Bermejo San Jose, Fernando, Bezuidenhout, Abraham, Biancone, Livia, Blaeker, Michael, Bloom, Stuart, Bokemeyer, Bernd, Bossa, Fabrizio, Bossuyt, Peter, Bouguen, Guillaume, Bouhnik, Yoram, Bouma, Gerd, Bourdages, Raymond, Bourreille, Arnaud, Boustiere, Christian, Brabec, Tomas, Brand, Stephan, Buening, Carsten, Buisson, Anthony, Cadiot, Guillaume, Calvet Calvo, Xavier, Carbonnel, Franck, Carpio, Daniel, Cheon, Jae Hee, Chiba, Naoki, Chioncel, Camelia, Cimpoeru, Nicoleta-Claudia, Clodi, Martin, Corazza, Gino Roberto, Cosintino, Rocco, Cotter, Jose, Creed, Thomas, Cummings, Fraser, Danese, Silvio, De' Angelis, Gian Luigi, De Maeyer, Marc, Desai, Milind, Desilets, Etienne, Desreumaux, Pierre, Dewit, Olivier, D'Haens, Geert, Dinter, Johanna, Dobru, Ecaterina Daniela, Douda, Tomas, Dumitrascu, Dan Lucian, Ebert, Matthias, Echarri Piudo, Ana, Elkhashab, Magdy, Eun, Chang Soo, Feagan, Brian, Fejes, Roland, Fidalgo, Catarina, Fishman, Sigal, Flourié, Bernard, Fowler, Sharyle, Fries, Walter, Fulop, Csaba, Fumery, Mathurin, G Kiss, Gyula, Gassner, Sonja, Gaya, Daniel, Germanà, Bastianello, Gheorghe, Liliana Simona, Gilletta de Saint Joseph, Cyrielle, Gionchetti, Paolo, Goldis, Adrian-Eugen, Gonçalves, Raquel, Grimaud, Jean-Charles, Gyökeres, Tibor, Hagege, Herve, Haidar, Andrei, Hartmann, Heinz, Hasselblatt, Peter, Hayee, Buhussain, Hebuterne, Xavier, Hellström, Per, Hindryckx, Pieter, Hlavova, Helena, Hoentjen, Frank, Howaldt, Stefanie, Hrdlicka, Ludek, Huh, Kyu Chan, Iborra Colomino, Maria Isabel, Ionita-Radu, Florentina, Irving, Peter, Jahnsen, Jørgen, Jang, ByungIk, Jansen, Jeroen, Jeon, Seong Woo, Jover Martinez, Rodrigo, Juillerat, Pascal, Karlén, Per, Kaser, Arthur, Keil, Radan, Kejariwal, Deepak, Keret, Dan, Khanna, Reena, Kim, Dongwoo, Kim, Duk Hwan, Kim, Hyo-Jong, Kim, Hyun-Soo, Kim, Joo Sung, Kim, Kueongok, Kim, Kyung-Jo, Kim, Sung Kook, Kim, Young-Ho, Klaus, Jochen, Kohn, Anna, Kojecky, Vladimir, Koo, Ja Seol, Kozak, Robert, Kremer, Milan, Kristof, Tunde, Kruger, Frederik, Laharie, David, Lahat-Zok, Adi, Landa, Evgeny, Lee, Jonghun, Lee, Kang-Moon, Lee, Kook Lae, Lee, YooJin, Lenze, Frank, Lim, Wee Chian, Limdi, Jimmy, Lindsay, James, Lopez Serrano, Pilar, Lueth, Stefan, Lukas, Milan, Maconi, Giovanni, Mana, Fazia, Mann, Steven, Mansfield, John, Marchi, Santino, Marino, Marco, Marshall, John, Martin Arranz, Maria Dolores, Mateescu, Radu-Bogdan, McLaughlin, John, McLaughlin, Simon, Melzer, Ehud, Mertens, Jessica, Mitrut, Paul, Molnar, Tamas, Muls, Vinciane, Munuswamy, Pushpakaran, Murray, Charles, Naftali, Timna, Naidoo, Visvakuren, Nanabhay, Yusuf, Negreanu, Lucian, Nguyen, Augustin, Ochsenkuehn, Thomas, Orlando, Ambrogio, Panaccione, Remo, Panes Diaz, Julian, Paritsky, Maya, Park, Dong Il, Park, Jihye, Pastorelli, Luca, Peck-Radosavljevic, Markus, Peerani, Farhad, Perez Gisbert, Javier, Peyrin-Biroulet, Laurent, Picon, Laurence, Pierik, Marieke, Ponich, Terry, Portela, Francisco, Prins, Maartens Jeroen, Racz, Istvan, Rahman, Khan Fareed, Reimund, Jean-Marie, Reinshagen, Max, Roblin, Xavier, Rocca, Rodolfo, Rogai, Francesca, Rogler, Gerhard, Salamon, Agnes, Salazar, Ennaliza, Sallo, Zoltan, Samuel, Sunil, Sans Cuffi, Miquel de Los Santos, Savarino, Edoardo Vincenzo, Savarino, Vincenzo, Savoye, Guillaume, Schreiber, Stefan, Seicean, Andrada, Selinger, Christian, Serra, David Martins, Shim, Hang Hock, Shin, SungJae, Siegmund, Britta, Siffledeen, Jesse, Simmonds, Wayne, Smid, Jan, Sollano, Jose, Song, Geun Am, Speight, Alexander, Sporea, Ioan, Staessen, Dirk, Stancu, George, Steel, Alan, Stepek, David, Stoica, Victor, Sturm, Andreas, Szekely, Gyorgy, Tan, Teck Kiang, Taxonera Samso, Carlos, Thomson, John, Tichy, Michal, Toth, Gabor Tamas, Tulassay, Zsolt, Vangeli, Marcello, Varga, Marta, Vieira, Ana, Viennot, Stephanie, Villa, Erica, Vitek, Petr, Vogelsang, Harald, Vyhnalek, Petr, Wahab, Peter, Walldorf, Jens, Ye, Byong Duk, Ziady, Christopher

المصدر: The Lancet Gastroenterology and Hepatology, 7 (2), 118-127 (2022-02)

مصطلحات موضوعية: Antibodies, Monoclonal, Humanized, Gastrointestinal Agents, B72HH48FLU (Infliximab), I2A72G2V3J (etrolizumab), Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized/therapeutic use, Colitis, Ulcerative/drug therapy, Double-Blind Method, Female, Gastrointestinal Agents/therapeutic use, Humans, Infliximab/therapeutic use, Injections, Subcutaneous, Male, Middle Aged, Severity of Illness Index, Treatment Outcome, Young Adult, Human health sciences, Gastroenterology & hepatology, Sciences de la santé humaine, Gastroentérologie & hépatologie

Relation: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00294-6/fulltext; 10.1016/S2468-1253(21)00294-6; urn:issn:2468-1253

URL الوصول: https://orbi.uliege.be/handle/2268/304714

المؤلفون: Peeters, H., Louis, Edouard, Baert, F., Dewit, O., Coche, J. C., Ferrante, M., Lambrecht, G., Colard, A., Van Gossum, A., Bossuyt, P., Moreels, T., Vander Cruyssen, B., Gils, A., De Vos, M.

المصدر: Acta Gastro-Enterologica Belgica, 81 (1), 15-21 (2018)

مصطلحات موضوعية: Adalimumab/therapeutic use, Adult, Aged, Belgium, Crohn Disease/drug therapy, Female, Gastrointestinal Agents/therapeutic use, Humans, Infliximab/therapeutic use, Male, Middle Aged, Prospective Studies, Treatment Outcome, Crohn's disease, adalimumab, infliximab, switching, Human health sciences, Gastroenterology & hepatology, Sciences de la santé humaine, Gastroentérologie & hépatologie

Relation: http://www.acta-gastroenterologica.be; urn:issn:1784-3227

URL الوصول: https://orbi.uliege.be/handle/2268/229798

المؤلفون: Jørn Brynskov, Nils Bolstad, Tobias Wirenfeldt Klausen, Casper Steenholdt, J. David Warren, Maria Dorn-Rasmussen, Jakob T Bay, Mark A. Ainsworth, Sine Buhl

المصدر: Dorn-Rasmussen, M, Buhl, S, Brynskov, J, Bay, J T, Bolstad, N, Klausen, T W, Warren, D J, Ainsworth, M A & Steenholdt, C 2022, ' Drug Levels Associated with Optimal Discrimination between Remission and Nonremission and Comparison of Antibody Assays during First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease ', Therapeutic Drug Monitoring, vol. 44, no. 2, pp. 290-300 . https://doi.org/10.1097/FTD.0000000000000913
Dorn-Rasmussen, M, Buhl, S, Brynskov, J, Bay, J T, Bolstad, N, Klausen, T W, Warren, D J, Ainsworth, M A & Steenholdt, C 2022, ' Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease ', Therapeutic Drug Monitoring, vol. 44, no. 2, pp. 290-300 . https://doi.org/10.1097/FTD.0000000000000913

مصطلحات موضوعية: medicine.medical_specialty, therapeutic drug monitoring, Inflammatory bowel disease, Gastroenterology, Antibodies, Maintenance therapy, Gastrointestinal Agents, inflammatory bowel disease, Internal medicine, Inflammatory Bowel Diseases/drug therapy, Dash, medicine, antibodies, Humans, Pharmacology (medical), antidrug antibodies, therapeutic thresholds, Retrospective Studies, Pharmacology, medicine.diagnostic_test, biology, business.industry, Retrospective cohort study, medicine.disease, Inflammatory Bowel Diseases, Infliximab, Infliximab/therapeutic use, Therapeutic drug monitoring, Immunoassay, biology.protein, Gastrointestinal Agents/therapeutic use, Antibody, Drug Monitoring, business, infliximab, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b978e34369bfe6178bf230e4186c8b9
https://pubmed.ncbi.nlm.nih.gov/34387220

المؤلفون: Kennedy, Nicholas A, Goodhand, James R, Bewshea, Claire, Nice, Rachel, Chee, Desmond, Lin, Simeng, Chanchlani, Neil, Butterworth, Jeffrey, Cooney, Rachel, Croft, Nicholas M, Hart, Ailsa L, Irving, Peter M, Kok, Klaartje B, Lamb, Christopher A, Limdi, Jimmy K, Macdonald, Jonathan, McGovern, Dermot Pb, Mehta, Shameer J, Murray, Charles D, Patel, Kamal V, Pollok, Richard Cg, Raine, Timothy, Russell, Richard K, Selinger, Christian P, Smith, Philip J, Bowden, Jack, McDonald, Timothy J, Lees, Charlie W, Sebastian, Shaji, Powell, Nicholas, Ahmad, Tariq, Contributors To The CLARITY IBD Study

المساهمون: Imperial College Healthcare NHS Trust- BRC Funding, Kennedy, Nicholas A [0000-0003-4368-1961], Goodhand, James R [0000-0003-3112-376X], Bewshea, Claire [0000-0002-0965-9587], Chee, Desmond [0000-0003-3473-9447], Lin, Simeng [0000-0002-4201-4879], Chanchlani, Neil [0000-0003-0207-6706], Cooney, Rachel [0000-0003-3710-157X], Croft, Nicholas M [0000-0002-1519-6435], Hart, Ailsa L [0000-0002-7141-6076], Irving, Peter M [0000-0003-0972-8148], Kok, Klaartje B [0000-0002-5942-9149], Lamb, Christopher A [0000-0002-7271-4956], Limdi, Jimmy K [0000-0002-1039-6251], McGovern, Dermot Pb [0000-0001-5621-759X], Mehta, Shameer J [0000-0002-7002-293X], Murray, Charles D [0000-0001-6736-1546], Patel, Kamal V [0000-0003-2611-4260], Pollok, Richard Cg [0000-0001-6452-6763], Raine, Timothy [0000-0002-5855-9873], Russell, Richard K [0000-0001-7398-4926], Selinger, Christian P [0000-0003-2022-5859], Smith, Philip J [0000-0003-1568-3978], Bowden, Jack [0000-0003-2628-3304], McDonald, Timothy J [0000-0003-3559-6660], Lees, Charlie W [0000-0002-0732-8215], Sebastian, Shaji [0000-0002-3670-6545], Powell, Nicholas [0000-0003-3231-6950], Ahmad, Tariq [0000-0002-6058-5528], Apollo - University of Cambridge Repository

المصدر: 2021, ' Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab ', Gut, vol. 70, no. 5, pp. 865-875 . https://doi.org/10.1136/gutjnl-2021-324388
Gut

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Antibody Formation/immunology, Principal–agent problem, inflammatory diseases, autoimmune disease, Antibodies, Monoclonal, Humanized, Antibodies, Viral, SARS-CoV-2/immunology, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Gastrointestinal Agents, inflammatory bowel disease, Inflammatory Bowel Diseases/drug therapy, Economics, Humans, clarity, Serologic Tests, Antibodies, Viral/immunology, Prospective Studies, vedoluzimab, COVID-19/epidemiology, Poverty, Gastroenterology & Hepatology, SARS-CoV-2, United Kingdom/epidemiology, Gastroenterology, COVID-19, 1103 Clinical Sciences, Neoclassical economics, Middle Aged, Inflammatory Bowel Diseases, Bounded rationality, United Kingdom, Contributors to the CLARITY IBD study, Infliximab/therapeutic use, 030104 developmental biology, Antibodies, Monoclonal, Humanized/therapeutic use, Antibody Formation, Gastrointestinal Agents/therapeutic use, 1114 Paediatrics and Reproductive Medicine, 030211 gastroenterology & hepatology, Female, infliximab

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document; text/xml

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6e01dd054652cb9b8697520d2d594a
https://hdl.handle.net/20.500.11820/1bfd49d0-2ff9-4251-9b80-3c64409dface

المؤلفون: Caroline Trang, Salima Hacein-Bey Abina, Malin Ryner, Florian Deisenhammer, Manuel Comabella, Abiba Doukani, Philippe Broët, Anna Fogdell-Hahn, Julianne Duhaze, Hans-Peter Hartung, Clemens Warnke, Natacha Szely, Delphine Bachelet, Alessandra Vultaggio, Bernd C. Kieseier, Sebastian Spindeldreher, Olivier Brocq, Poul Erik Hyldgaard-Jensen, Michael Auer, Marc Pallardy, Matthieu Allez, Mary Birchler, Tom W J Huizinga, Yehuda Chowers, Yoram Bouhnik, Dorothea Buck-Martin, Elizabeth C. Jury, Amy Loercher, Dan Sikkema, Aude Gleizes, Tobias Derfuss, Jessica J Manson, Guillaume Cadiot, Claudia Sievers, Michael Khalil, Naoimh Donnellan, Raija L.P. Lindberg, Agnès Hincelin Mery, Badreddine Mohand Oumoussa, Enrico Maggi, Martin Soubrier, Kathleen Ingenhoven, Orhan Aktas, Sophie Tourdot, Xavier Montalban, Maria Nachury, Niek de Vries, Timothy P. Hickling, Christophe Richez, Bernhard Hemmer, Franck Carbonnel, Finn Sellebjerg, Jérôme Avouac, Petra Nytrova, Xavier Mariette, Anna Lauren, Signe Hässler, Pierre Dönnes, Eva Havrdova, Michael Guger, Claudia Mauri

المساهمون: BRUNEL, Nadège, Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière] (I3), CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Institut de médecine et d'épidémiologie appliquée [AP-HP Hôpital Bichat-Claude Bernard] (IMEA), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Sainte Justine [Montréal], Université Paris-Saclay, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS - UM 4 (UMR 8258 / U1022)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Université Paris Cité - UFR Médecine [Santé] (UPCité UFR Médecine), Université Paris Cité (UPCité), GlaxoSmithKline, Glaxo Smith Kline, Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Princesse Grace [Monaco], Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Hôpital universitaire Robert Debré [Reims], University of Haifa [Haifa], Universitat Autònoma de Barcelona (UAB), University Hospital Basel [Basel], VU University Medical Center [Amsterdam], Royal Berkshire Hospital, Plateforme Post-génomique de la Pitié-Salpêtrière (PASS-P3S), Unité Mixte de Service Production et Analyse de données en Sciences de la vie et en Santé (PASS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Kepler University Hospital, University Hospital Düsseldorf, Charles University [Prague] (CU), Leiden University Medical Center (LUMC), Rigshospitalet [Copenhagen], Copenhagen University Hospital, University College of London [London] (UCL), Karl-Franzens-Universität Graz, Malmö Högskola = Malmö University, University of Basel (Unibas), Università degli Studi di Firenze = University of Florence (UniFI), University College London Hospitals (UCLH), Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille], Hôpital Claude Huriez [Lille], CHU Lille-CHU Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU de Bordeaux Pellegrin [Bordeaux], Karolinska Institutet [Stockholm], CHU Clermont-Ferrand, Université de Florence, Fachhochschule Köln, University of Skövde [Sweden], Pfizer, SANOFI Recherche, Hopital Saint-Louis [AP-HP] (AP-HP), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de Chimie du CNRS (INC)-Université de Paris (UP)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Dusseldorf, Innsbruck Medical University [Austria] (IMU), Université de Paris - UFR Médecine Paris Centre [Santé] (UP Médecine Paris Centre), Université de Paris (UP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Karl-Franzens-Universität [Graz, Autriche], Malmø University, Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), University of Graz, AII - Inflammatory diseases, Clinical Immunology and Rheumatology

المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS Medicine
PLoS Medicine, 17(10). PUBLIC LIBRARY SCIENCE
PLoS Medicine, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩
Hässler, S, Bachelet, D, Duhaze, J, Szely, N, Gleizes, A, Hacein-Bey Abina, S, Aktas, O, Auer, M, Avouac, J, Birchler, M, Bouhnik, Y, Brocq, O, Buck-Martin, D, Cadiot, G, Carbonnel, F, Chowers, Y, Comabella, M, Derfuss, T, De Vries, N, Donnellan, N, Doukani, A, Guger, M, Hartung, H-P, Kubala Havrdova, E, Hemmer, B, Huizinga, T, Ingenhoven, K, Hyldgaard-Jensen, P E, Jury, E C, Khalil, M, Kieseier, B, Laurén, A, Lindberg, R, Loercher, A, Maggi, E, Manson, J, Mauri, C, Mohand Oumoussa, B, Montalban, X, Nachury, M, Nytrova, P, Richez, C, Ryner, M, Sellebjerg, F, Sievers, C, Sikkema, D, Soubrier, M, Tourdot, S, Trang, C, Vultaggio, A & ABIRISK Consortium 2020, ' Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease : A prospective multicohort study of the ABIRISK consortium ', PLoS Medicine, vol. 17, no. 10, e1003348 . https://doi.org/10.1371/journal.pmed.1003348
PLoS Medicine, Public Library of Science, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩
PLoS Medicine, Vol 17, Iss 10, p e1003348 (2020)
PLoS medicine, 17(10):e1003348. Public Library of Science

مصطلحات موضوعية: Male, Physiology, [SDV]Life Sciences [q-bio], Single Nucleotide Polymorphisms, Autoimmune Diseases/drug therapy, Biological Therapy/methods, Arthritis, 030204 cardiovascular system & hematology, Biochemistry, Inflammatory bowel disease, Etanercept, Arthritis, Rheumatoid, Cohort Studies, chemistry.chemical_compound, Medical Conditions, 0302 clinical medicine, Crohn Disease, Antibiotics, Immune Physiology, Medicine and Health Sciences, Prospective Studies, 030212 general & internal medicine, ComputingMilieux_MISCELLANEOUS, Immune System Proteins, Antimicrobials, Drugs, Neurodegenerative Diseases, General Medicine, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Biological Therapy, Antibodies, Monoclonal, Humanized/therapeutic use, Neurology, Arthritis, Rheumatoid/drug therapy, Rheumatoid arthritis, Genome-Wide Association Study/methods, Medicine, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Rituximab, Immunosuppressive Agents, Interferon beta-1a, Research Article, medicine.drug, Adult, Multiple Sclerosis, [SDV.IMM] Life Sciences [q-bio]/Immunology, Immunology, Rheumatoid Arthritis, Gastroenterology and Hepatology, Antibodies, Monoclonal, Humanized, Microbiology, Antibodies, HLA-DQ alpha-Chains, Autoimmune Diseases, 03 medical and health sciences, Tocilizumab, Rheumatology, Adalimumab/therapeutic use, Microbial Control, HLA-DQ alpha-Chains/genetics, Rituximab/therapeutic use, Genetics, medicine, Adalimumab, Humans, Antigens, Biological Products/immunology, Pharmacology, Biological Products, Interferon beta-1a/therapeutic use, business.industry, Inflammatory Bowel Disease, Biology and Life Sciences, Proteins, medicine.disease, Demyelinating Disorders, Infliximab, Minor allele frequency, Infliximab/therapeutic use, chemistry, Crohn Disease/drug therapy, Immunosuppressive Agents/therapeutic use, Multiple Sclerosis/drug therapy, Clinical Immunology, Colitis, Ulcerative, Clinical Medicine, Colitis, Ulcerative/drug therapy, business, Genome-Wide Association Study

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f38afd466f71b9ab3ba9e7e10f54091
https://doi.org/10.1371/journal.pmed.1003348

المؤلفون: Alexander A. Navarini, Curdin Conrad, Alessio Mylonas, Anne-Karine Lapointe, Jeremy Di Domizio, Olivier Demaria, Michel Gilliet, Cyrine Belkhodja, Lars E. French, Maxime Vernez

المساهمون: University of Zurich, Conrad, Curdin

المصدر: Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications
Nature communications, vol. 9, no. 1, pp. 25

مصطلحات موضوعية: 0301 basic medicine, Male, T-Lymphocytes, General Physics and Astronomy, Autoimmunity, medicine.disease_cause, 030207 dermatology & venereal diseases, 0302 clinical medicine, Crohn Disease, Interferon, lcsh:Science, Cells, Cultured, Mice, Inbred BALB C, Multidisciplinary, 10177 Dermatology Clinic, Antibodies, Monoclonal, Middle Aged, 3100 General Physics and Astronomy, Adalimumab/adverse effects, Adalimumab/immunology, Adalimumab/therapeutic use, Adolescent, Adult, Aged, Animals, Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal/immunology, Antibodies, Monoclonal/therapeutic use, Autoimmunity/drug effects, Autoimmunity/immunology, Crohn Disease/drug therapy, Crohn Disease/immunology, Crohn Disease/metabolism, Cytokines/genetics, Cytokines/immunology, Cytokines/metabolism, Dendritic Cells/drug effects, Dendritic Cells/immunology, Dendritic Cells/metabolism, Female, Humans, Infliximab/adverse effects, Infliximab/immunology, Infliximab/therapeutic use, Interferon Type I/genetics, Interferon Type I/immunology, Interferon Type I/metabolism, Psoriasis/chemically induced, Psoriasis/immunology, T-Lymphocytes/drug effects, T-Lymphocytes/immunology, T-Lymphocytes/metabolism, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Tumor Necrosis Factor-alpha/immunology, Tumor Necrosis Factor-alpha/metabolism, Young Adult, Interferon Type I, Cytokines, Tumor necrosis factor alpha, medicine.drug, Science, 610 Medicine & health, 1600 General Chemistry, General Biochemistry, Genetics and Molecular Biology, Article, 03 medical and health sciences, 1300 General Biochemistry, Genetics and Molecular Biology, Psoriasis, medicine, Adalimumab, business.industry, Tumor Necrosis Factor-alpha, General Chemistry, Dendritic Cells, medicine.disease, Type I interferon production, Infliximab, 030104 developmental biology, Immunology, lcsh:Q, business, Interferon type I

وصف الملف: application/pdf; 2018_LF_TNF_blockade_induces_a_dysregulated_type_I_interferon_response_without_autoimmunity_in_paradoxical_psoriasis.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbc7decb248c10970a313c075620f0f
https://doaj.org/article/180fc992d72e4fcbbf1d606055e86015

المؤلفون: V Pereira, Ricardo Figueira, C.S.C.R. Andrade, Goreti Faria, Luís Jasmins

المصدر: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
GE-Portuguese Journal of Gastroenterology v.24 n.2 2017
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Anti-nuclear antibody, Doenças inflamatórias intestinais, tratamento, Lupus erythematosus, systemic/chemically induced, Gastroenterology, Lupus eritematoso, sistémico/induzido quimicamente, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Inflammatory bowel diseases, drug therapy, skin and connective tissue diseases, Proctitis, General Environmental Science, 030203 arthritis & rheumatology, Lupus erythematosus, Systemic lupus erythematosus, medicine.diagnostic_test, business.industry, Infliximab, therapeutic use, Hydroxychloroquine, medicine.disease, Rash, Clinical Case Study, Infliximab, Surgery, Factor de necrose tumoral alfa, uso terapêutico, Erythrocyte sedimentation rate, General Earth and Planetary Sciences, 030211 gastroenterology & hepatology, Infliximab, uso terapêutico, medicine.symptom, Tumor necrosis factor alpha, therapeutic use, business, medicine.drug

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ae4d46090d38082d050e29f779cd88
https://doi.org/10.1159/000450877

المؤلفون: Kisić, Mateja, Vukosav, Vinka, Valetić, Ana Marija, Čulo, Melanie-Ivana, Morović-Vergles, Jadranka

المصدر: Liječnički vjesnik
Volume 140
Issue 9-10

مصطلحات موضوعية: Arthritis, rheumatoid – complications, drug therapy, Osteoporosis – complications, drug therapy, physiopathology, Osteoporotic fractures – etiology, Rib fractures – etiology, Antirheumatic agents – therapeutic use, Glucocorticoids – adverse effects, therapeutic use, Infliximab – therapeutic use, Bone density, Densitometry, Deskriptori: Reumatoidni artritis – farmakoterapija, komplikacije, Osteoporoza –farmakoterapija, komplikacije, patofiziologija, Osteoporotski prijelomi – etiologija, Prijelomi rebara – etiologija, Antireumatici – terapijska primjena, Glukokortikoidi – neželjeni učinci, terapijska primjena, Infliksimab – terapijska primjena, Koštana gustoća, Denzitometrija

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______951::0d53afaccc585afc9bc49ccc2fb6ac98
https://hrcak.srce.hr/209136

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.